Please assess the completion status of the following clinical trial:

Trial Title: Trial Comparing Outcomes With Merocel Packing or Thrombin-JMI for Anterior Epistaxis

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* English speaking adults that have failed first line therapy for anterior epistaxis in the ER or the hospital~Exclusion Criteria:~* Non-english speaking patients~* Patients with bleeding disorders~* Known pregnant women or women that think they may be pregnant~* Patients with a know presence of antibodies to bovine thrombin preparations~* Patients that currently have or are known to have a history of systemic skin condition or rash such as eczema or psoriasis~* Patients found to have posterior epistaxis~* Patients requiring a surrogate for medical decisions

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- 1 (Type: EXPERIMENTAL): Thrombin-JMI
- 2 (Type: ACTIVE_COMPARATOR): Merocel pack

Based on this trial design, predict the completion outcome and termination type (if applicable).